Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endologix, Inc issues FY 2014 guidance below analysts' estimates

Thursday, 27 Feb 2014 04:07pm EST 

Endologix, Inc:Expects FY 2014 revenue to be in the range of $146 mln to $152 mln.Expects GAAP FY 2014 loss per share in the range of ($0.31) to ($0.44) per share.Expects FY 2014 adjusted EBITDA in the range of $(0.04) to $(0.17) per share.FY 2014 revenue of $161 mln and EPS at breakeven - Thomson Reuters I/B/E/S. 

Company Quote

-0.3 -2.60%
22 Oct 2014